ClinicalTrials.gg
Not yet recruitingNCT07911722PATHHUpdated Nov 6, 2026

A Patient Navigation Trial for Housing and Health (PATHH)

An interventional study of PATHH in Housing Instability and Health and Social Services, sponsored by Friends Research Institute, Inc.. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Friends Research Institute, Inc. · Not applicable, Interventional, and Supportive care

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study will describe and evaluate the experiences and outcomes of women who have survived violence and also have medical needs. The intervention being tested is a service called 'PATHH', a patient navigation service that extends after a stay in an emergency shelter. Some people who join the study will work with the PATHH patient navigator, and some will receive standard care at the community shelter. Participants who are assigned the PATHH navigator will receive additional support and help linking with services in the community during and after their emergency shelter stay. By doing this study, how patient navigation services affect the health and housing stability among women who have survived violence will be better understood.

Read the detailed description

Enrollment in this randomized controlled trial will last 12 months. Participants will be asked to complete four research visits consisting of surveys and a saliva sample to test for recent drug and alcohol use. The first research visit (baseline) will occur at the emergency shelter or at the drop-in center. Additional research visits will occur 3-, 6-, and 12-months after discharge from the emergency shelter.

Participants will be randomly assigned to one of two groups: Usual Care or PATHH Patient Navigation. PATHH Patient Navigation participants will be asked to meet with a navigator while they are receiving services at the emergency shelter and/or drop-in center, and after they leave the emergency shelter for 3-months. The navigators will visit with participants in-person and can also communicate by phone, text, and email. They will work with participants to offer support and help linking participants with recommended health and housing services. The primary outcomes are increased housing stability and health self-efficacy.

02

Conditions studied

  • Housing Instability
  • Health and Social Services

Keywords

  • women survivors of violence
  • patient navigation
03

In context

Lead sponsor

Friends Research Institute, Inc. is the lead sponsor of 45 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. self-identify as a woman;
  2. are age 18 or older
  3. report a history of physical or sexual violence in the last year using the Revised Conflict Tactics Scale
  4. report a qualifying health condition requiring ongoing engagement in healthcare and commonly occurring in this population, including substance use disorder, depression, and/or .

Exclusion criteria

Exclusion Criteria:

  1. current stable housing
  2. inability or unwillingness to provide in English.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    PATHH

    The intervention will consist of TAU services plus 12 weeks of services provided by a trained patient navigator. Patient Navigators will meet with the participants the day they are randomized to the intervention and will remain engaged with the participants throughout their emergency shelter stay. The navigator will continue to engage PATHH participants for 12 weeks post-discharge from emergency shelter.

    Behavioral: PATHH

  • No intervention
    Treatment as Usual

    Treatment as usual consists of routine services provided by housing and affiliated community organizations, which include case management services that assist with rent, transitional housing, food, clothes, and peer support services.

Interventions

  • BehavioralPATHH

    The intervention will consist of TAU services plus 12 weeks of services provided by a trained patient navigator. Patient Navigators will meet with the participants the day they are randomized to the intervention and will remain engaged with the participants throughout their emergency shelter stay. The navigator will continue to engage PATHH participants for 12 weeks post-discharge from emergency shelter.

    Also known as: Patient Navigation for Housing and Health

06

What researchers measure

Primary outcomes

  1. Housing Stability

    The primary outcome examining housing stability will be defined as obtaining housing (yes/no) within 6-months following departure from the emergency shelter stay. Housing will be inclusive of placements into transitional, supportive, and/or permanent housing locations and will be consistent with the Department of Housing and Urban Development (HUD) definition of stable housing, indicating any housing that meets safety standards and where the occupant has the rights and responsibilities of a tenant.

    Time frame: 6-months from departure or discharge from the emergency shelter stay

  2. Health self-efficacy

    Healthcare self-efficacy will be operationalized using the 22-item Patient Activation Measure (PAM81). The PAM is a reliable and valid measure that has demonstrated strong psychometric properties in several contexts and settings and assesses an individual's knowledge, skills, and confidence in managing their health needs and navigating health systems. Scores from PAM item responses are categorized into four levels of activation, ranging from Level 1 (the patient is disengaged and overwhelmed, and adherence is poor) to Level 4 (the patient has high health knowledge and maintaining health lifestyle is the focus).

    Time frame: 6-months from departure or discharge from the emergency shelter stay

Secondary outcomes

  1. Housing Insecurity

    Perceptions of Housing Insecurity will be assessed through a 2-item Health Related Social Needs screening tool that assesses the current living situation and its perception of stability, decency and safety in terms of heat, pests, lead paint, water leaks, and other housing conditions. A positive screening result indicates greater housing insecurity or unmet housing-related needs.

    Time frame: 3-, 6- and 12- months post enrollment

  2. Housing Instability

    Perceptions of housing instability will be assessed using the Housing Instability Scale, which is a seven-item scale that was created and validated among survivors of domestic violence, with higher scores indicating greater housing instability. Scores range from 0 to 7, with higher scores indicating greater housing instability.

    Time frame: 3-, 6-, and 12-months post enrollment

  3. Social Support

    Social Support: Social support will be measured using the Medical Outcomes Study (MOS) Social Support Survey, a 19-item questionnaire. Responses will be transformed to a standardized scale ranging from 0 to 100, with higher scores indicating greater perceived availability of social support.

    Time frame: 3-, 6- and 12-months post enrollment

  4. Global Health

    Physical, social, and mental health functioning will be assessed through the Promis 10 Global Health scale. Possible scores range from 16.2 to 67.7 for physical health and 21.2 to 67.6 for mental health. Higher scores indicate better health functioning.

    Time frame: 3-, 6-, and 12-months post enrollment

  5. Mental Health Symptoms

    PHQ-8 will be used to assess depressive symptoms; total scores range from 0 to 24, with higher scores indicating greater depressive symptom severity.

    Time frame: 3-, 6-, 12- months post enrollment

  6. History of Violence

    Lifetime exposure to stressful and potentially traumatic events will be assessed using the 13-item Stressful Life Events Screening Questionnaire (SLESQ). The instrument assesses exposure to events such as life-threatening accidents, physical and sexual assault, and witnessing violence. Each event category is assessed using a yes/no response, with additional questions characterizing the exposure. The total score is calculated by summing the number of event categories endorsed, ranging from 0 to 13, with higher scores indicating greater lifetime exposure to potentially traumatic events.

    Time frame: 3-, 6-, and 12-months post enrollment.

07

Study locations

1 site
  • Friends Research Institute
    Philadelphia, Pennsylvania 19122, United States
08

References and documents

Individual participant data

Plan to share: No — The study team will only share deidentified data after study outcomes have been analyzed to an NIH approved depository.

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Secondary outcomes
6 description edited
What changed in the outcomes
  • DescriptionGlobal Health: how it is measured was reworded
  • DescriptionHistory of Violence: how it is measured was reworded
  • DescriptionHousing Insecurity: how it is measured was reworded
  • DescriptionHousing Instability: how it is measured was reworded
  • DescriptionMental Health Symptoms: how it is measured was reworded
  • DescriptionSocial Support: how it is measured was reworded
Nov 6, 2026
Registered
First appeared on the registry
Nov 3, 2026
Show all 2 updates
  1. Nov 6, 2026
    Secondary outcomes 6 description edited
    What changed in the outcomes
    • DescriptionGlobal Health: how it is measured was reworded
    • DescriptionHistory of Violence: how it is measured was reworded
    • DescriptionHousing Insecurity: how it is measured was reworded
    • DescriptionHousing Instability: how it is measured was reworded
    • DescriptionMental Health Symptoms: how it is measured was reworded
    • DescriptionSocial Support: how it is measured was reworded
    + 2 other changes: description and data sharing statement
  2. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07911722
Lead sponsor
Friends Research Institute, Inc.
Responsible party
Sponsor
First posted
Nov 3, 2026
Start date
Nov 11, 2026 (estimated)
Primary completion
Aug 2030 (estimated)
Completion
Aug 2030 (estimated)
Last update
Nov 6, 2026

Study contacts

Karen Alexander, PhD, RN
Contact
kalexander@friendsresearch.org
9084510141
Courtney Nordeck, PhD
Contact
cnordeck@friendsresearch.org
410-458-5399
Karen Alexander, PhD
principal investigator · Friends Research Institute, Inc.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion